| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5695871 | Gynecologic Oncology | 2017 | 5 Pages |
Abstract
These findings indicate that TPB for recurrent SCCC significantly improved PFS over non-TPB regimens, and trends towards improved OS. Furthermore, a significant number of patients had a durable clinical benefit.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
M. Frumovitz, M.F. Munsell, J.K. Burzawa, L.A. Byers, P. Ramalingam, J. Brown, R.L. Coleman,